Guangdong Raynovent Biotech Co., Ltd clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.
- Minor: ZSP1273 in Adolecent 12-17 Years Old With Influenza A Trial completed
- Minor: ZSP1273 in Children 2-11 Years Old With Influenza A Trial completed
- Minor: RAY1225 · Type 2 Diabetes Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 3 | |
| Phase 2 | 2 | |
| Phase 3 | 3 |
Disease areas by active trials
Obesity (3) · Diabetes (2) · Type 2 Diabetes (2) · NASH / MASH (1)
Get alerts when Guangdong Raynovent Biotech Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.